AUTLNasdaq United Kingdom
Market cap
$561.589 M
$2.11 +5.50%
Close of 7 Aug 2026
Revenue
$10.1M
#3166 by revenue
Earnings
-$287.5M
Loss-making
Shares outstanding
266,143,286
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Autolus Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.